Company / Cash per Share
Ginkgo Bioworks Holdings, Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.08
FY2025
5-year range
$0.50 / $11.22
FY2021-FY2025
Trend
-72.6%
vs FY2024
Sector context
#72 of 207
Health Care
What the data says
At $3.08, Ginkgo Bioworks Holdings, Inc.'s cash per share ranks #72 of 207 in the Health Care sector. Cash per Share has fluctuated over the past 7 years, ranging from $0.30 in FY2020 to $11.22 in FY2024.
Based on SEC 10-K filings.
3.08 in FY2025 with a 5-year CAGR of +59.4%.
Improved from $0.50 to $3.08 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +55.6%
- 5-Year CAGR
- +59.4%
- 10-Year CAGR
- -
Sector benchmark
#72 of 207 in Health CareTop 35% of 207This company $3.08 Sector average $67.39
▼
-95.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 72.6% year-over-year.
- Ranks #72 out of 207 companies in the Health Care sector.
- Peak cash per share was recorded in FY2024.
- Lowest cash per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.08 | -72.6% |
| FY2024 | $11.22 | +2149.4% |
| FY2023 | $0.50 | -38.9% |
| FY2022 | $0.82 | -32.1% |
| FY2021 | $1.20 | +302.7% |
| FY2020 | $0.30 | -30.7% |
| FY2019 | $0.43 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026